HIV associated nephropathy epidemiology and demographics

Revision as of 18:00, 18 September 2017 by WikiBot (talk | contribs) (Changes made per Mahshid's request)
Jump to navigation Jump to search

HIV associated nephropathy Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating HIV associated nephropathy from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

KUB X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

HIV associated nephropathy epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of HIV associated nephropathy epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on HIV associated nephropathy epidemiology and demographics

CDC on HIV associated nephropathy epidemiology and demographics

HIV associated nephropathy epidemiology and demographics in the news

Blogs on HIV associated nephropathy epidemiology and demographics

Directions to Hospitals Treating HIV associated nephropathy

Risk calculators and risk factors for HIV associated nephropathy epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Ali Poyan Mehr, M.D. [2];Associate Editor(s)-in-Chief: Krzysztof Wierzbicki M.D. [3]

Overview

Epidemiology

Prevalence

The prevalence of HIV-associated nephropathy in the United States and in Western European countries is estimated to range form 3 to 12 percent each year. The prevalence rate of HIV-associated neohropathy in children is estimated to be 10 to 15 percent each year. Though, there has been a decline in the incidences of HIV-associated nephropathy thank in part to the advent of HAART theraphy, which prolongs renal survival time.

Incidence

The incidence of HIV-associated nephropathy in the United States is estimated to be around 800 to 900 new cases per year.

Demographics

The rate distribution of HIV-associated nephropathy varies upon, age, sex, and race.

Age

The onset at which HIV-associated nephropathy occurs is between the ages of 20 and 64 years of age. The average age at which patients are affected with HIV-associated nephropathy is around 40.8 years of age.

Gender

HIV-associated nephropathy affects more men than women, with a male to female ratio of 10:1.

Race

HIV-associated nephropathy effects blacks more commonly than any other race.

References

Template:WH Template:WS